ChondroGene Inc.

27 articles about ChondroGene Inc.

• GeneNews To Present At Rodman & Renshaw Techvest 8th Annual Healthcare Conference

  10/31/2006

• ChondroGene Inc. Announces Name Change To GeneNews

  10/23/2006

• ChondroGene Inc. Receives Conditional Approval To Trade On The Toronto Stock Exchange

  9/22/2006

• Molecular Diagnostics Industry Executive, Dr. Heiner Dreismann, Joins ChondroGene Inc.'s Board

  9/19/2006

• Webcast Alert: ChondroGene Limited Announces Its InformedInvestors.com Presentation Webcast

  8/23/2006

• ChondroGene Inc. Reports Second Quarter 2006 Financial Results

  8/17/2006

• ChondroGene Inc.'s Dr. Daniel H. Farkas Chairs And Opens American Association for Clinical Chemistry Annual Meeting

  7/21/2006

• ChondroGene Inc. Presenting At 11th Annual Society Of Chinese Bioscientists In America Meeting

  7/20/2006

• ChondroGene Inc. Release: Application Of Sentinel Principle In Bladder Cancer Published In Clinical Cancer Research

  6/19/2006

• ChondroGene Inc. Release: Blood-Based Detection Of Colon And Prostate Cancer Abstracts Presented At American Society of Clinical Oncology Annual Meeting

  6/7/2006

• ChondroGene Inc. Reports First Quarter 2006 Financial Results

  5/31/2006

• ChondroGene Inc. Appoints David Tyler Director, Product Development And Quality Assurance

  5/10/2006

• ChondroGene Inc. Partners With Kaiser Permanente

  4/27/2006

• ChondroGene Inc. Release: Colon And Prostate Cancer Abstracts Accepted By American Society of Clinical Oncology

  4/25/2006

• ChondroGene Inc. To Sponsor And Present At Medical Botechnology Symposium In Malaysia

  3/24/2006

• ChondroGene Inc. Reports On Blood-Based Prostate Cancer Diagnostic Test Development

  3/22/2006

• ChondroGene Inc. Release: Sentinel Principle(TM) Paper Published In Journal Of Laboratory And Clinical Medicine

  3/10/2006

• ChondroGene Inc. Reports 2005 Fourth Quarter And Year End Financial Results

  3/8/2006

• ChondroGene Inc. Reports On Blood-Based Colon Cancer Test Development; Identifies Five-Gene Colon Cancer Biomarker

  2/22/2006

• ChondroGene Inc. Appoints Dr. Daniel H. Farkas VP Clinical Diagnostics

  12/1/2005